Skip to main content

Table 1 Baseline demographic, clinical, laboratory and medication-related characteristics of children on ART at Debre-Markos Referral Hospital, Northwest Ethiopia from March 2005 to April 2017 (n = 352)

From: Incidence of tuberculosis in children on antiretroviral therapy: a retrospective cohort study

Characteristics Categories Frequency Percent (%)
Age 0–5 year 140 39.8
5–10 year 154 43.7
10–15 year 58 16.5
Sex Male 179 50.9
Female 173 49.1
Residence Urban 313 88.9
Rural 39 11.1
Parent status Both parents alive 248 70.5
Paternal and maternal orphan 80 22.7
Double orphan 24 6.8
WHO clinical stage Stage 1 and 2 275 78.1
Stage 3 and 4 77 21.9
CD4 count Below threshold 69 19.6
Above threshold 283 80.4
Hemoglobin level < 10 mg/dl 50 14.2
≥ 10 mg/dl 302 85.8
Nutritional status Underweight 82 22.3
Normal 270 76.7
Ever taking cotrimoxazole preventive therapy Yes 331 94.0
No 21 6.0
Ever taking isoniazid prophylaxis therapy Yes 110 31.2
No 242 68.8
Months on care before ART ≤ 3 month 290 82.4
> 3 months 62 17.6
ART adherence Good 301 85.5
Ever had fair and poor 51 14.5
Months on care after ART ≤ 6 month 56 15.9
> 6 month 296 84.1
  1. ART antiretroviral therapy, WHO World Health Organization